Xilio Therapeutics grants inducement stock options for 19,865 shares at $8.88 each
XLO•Inducement stock options granted to two new employees
Xilio Therapeutics granted non-qualified stock options covering 19,865 common shares to two new employees, effective Sept. 1, 2026.
The exercise price was set at $8.88 per share, matching the Sept. 1 closing price, and the options carry a 10-year term.
The vesting schedule calls for 25% after one year and the remaining 75% in 36 equal monthly installments, contingent on continued service.
